Brief: Hemcheck Sweden AB - Q4 Pretax Loss Sek 3.1 Million
Feb 19 (Reuters) - Hemcheck Sweden AB HEMC.ST :
* HEMCHECK SWEDEN AB - Q4 OPERATING REVENUE SEK 0.1 MILLION VERSUS SEK 0 MILLION YEAR AGO
* HEMCHECK SWEDEN AB - Q4 PRETAX LOSS SEK 3.1 MILLION VERSUS LOSS SEK 1.3 MILLION YEAR AGO
Source text for Eikon: ID:nWkrCp2vJ
Further company coverage: HEMC.ST
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Bio Vitos Pharma AB
See all newsAdvisory: Alerts on Bio Vitos Pharma withdrawn
Brief: Bio Vitos Pharma Q4 Operating Revenue Falls To SEK 0.3 Mln
Brief: Bio Vitos Reaches Settlement With Norvolt AS, Norvolt Capital AS
Brief: Bio Vitos Pharma Appoints Sven Rohmann As Acting CEO
Brief: Bio Vitos Pharma Q3 Loss After Financial Items SEK 3.0 Mln